These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12107621)

  • 1. A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia.
    Fitzgerald PB; Brown TL; Daskalakis ZJ; Kulkarni J
    Psychopharmacology (Berl); 2002 Jun; 162(1):74-81. PubMed ID: 12107621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports.
    Puri BK; Davey NJ; Zaman R
    Int J Clin Pract; 2003 Nov; 57(9):831-3. PubMed ID: 14686575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia.
    Fitzgerald PB; Brown TL; Daskalakis ZJ; Kulkarni J
    Psychiatry Res; 2002 Feb; 114(1):11-22. PubMed ID: 11864806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic treatment with quetiapine increases the cortical silent period.
    Frank E; Landgrebe M; Poeppl TB; Schecklmann M; Kreuzer PM; Prasser J; Rupprecht R; Eichhammer P; Hajak G; Langguth B
    Schizophr Res; 2014 Jun; 156(1):128-32. PubMed ID: 24794881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation.
    Daskalakis ZJ; Christensen BK; Chen R; Fitzgerald PB; Zipursky RB; Kapur S
    Arch Gen Psychiatry; 2002 Apr; 59(4):347-54. PubMed ID: 11926935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study.
    Broerse A; Crawford TJ; den Boer JA
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):454-60. PubMed ID: 12426415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaco-transcranial magnetic stimulation studies of motor excitability.
    Ziemann U
    Handb Clin Neurol; 2013; 116():387-97. PubMed ID: 24112911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excitability of human cortical inhibitory circuits responsible for the muscle silent period after transcranial brain stimulation.
    Bertasi V; Bertolasi L; Frasson E; Priori A
    Exp Brain Res; 2000 Jun; 132(3):384-9. PubMed ID: 10883387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical motor neurophysiology of patients with schizophrenia: a study using transcranial magnetic stimulation.
    Soubasi E; Chroni E; Gourzis P; Zisis A; Beratis S; Papathanasopoulos P
    Psychiatry Res; 2010 Apr; 176(2-3):132-6. PubMed ID: 20202691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drugs and cortical excitability: a study with repetitive transcranial stimulation.
    Inghilleri M; Conte A; Frasca V; Curra' A; Gilio F; Manfredi M; Berardelli A
    Exp Brain Res; 2004 Feb; 154(4):488-93. PubMed ID: 14579005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
    Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
    Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.
    Wobrock T; Schneider-Axmann T; Retz W; Rösler M; Kadovic D; Falkai P; Schneider M
    Pharmacopsychiatry; 2009 Sep; 42(5):194-201. PubMed ID: 19724982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of psychotropic drugs on cortical excitability of patients with major depressive disorders: A transcranial magnetic stimulation study.
    Khedr EM; Elserogy Y; Fawzy M; Abdelrahman AA; Galal AM; Noaman MM
    Psychiatry Res; 2020 Sep; 291():113287. PubMed ID: 32763548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha2-adrenergic agonist guanfacine reduces excitability of human motor cortex through disfacilitation and increase of inhibition.
    Korchounov A; Ilić TV; Ziemann U
    Clin Neurophysiol; 2003 Oct; 114(10):1834-40. PubMed ID: 14499745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation.
    Fitzgerald PB; Brown TL; Daskalakis ZJ; deCastella A; Kulkarni J
    Schizophr Res; 2002 Aug; 56(3):199-209. PubMed ID: 12072169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.
    Strube W; Wobrock T; Bunse T; Palm U; Padberg F; Malchow B; Falkai P; Hasan A
    Behav Brain Res; 2014 May; 264():17-25. PubMed ID: 24509248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical excitability in drug naive juvenile myoclonic epilepsy.
    Puri V; Sajan PM; Chowdhury V; Chaudhry N
    Seizure; 2013 Oct; 22(8):662-9. PubMed ID: 23746624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
    Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL
    Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic nicotine consumption on motor cortical excitability: A transcranial magnetic stimulation study.
    Khedr EM; Tony AA; Abdelwarith A; Safwat M
    Neurophysiol Clin; 2020 Feb; 50(1):33-39. PubMed ID: 31836418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.